Discontinued — last reported Q4 '18
High levels suggest a capital-intensive segment with significant ongoing investment in infrastructure or acquired intangibles.
The non-cash expense allocated to the Nutrition and Biosciences segment representing the systematic allocation of the co...
Standard 'Segment D&A' reported by industrial companies to reconcile operating income to cash flow.
dd_segment_nutrition_and_biosciences_depreciation_depletion_and_amortization